BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16939703)

  • 1. Study of a pingyangmycin delivery system: Zein/Zein-SAIB in situ gels.
    Gao Z; Ding P; Zhang L; Shi J; Yuan S; Wei J; Chen D
    Int J Pharm; 2007 Jan; 328(1):57-64. PubMed ID: 16939703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of microdialysis to study the in vivo release of pingyangmycin from in situ gels in rabbits.
    Gao ZB; Ding PT; Zhang L; Yuan ZT; Shi J; Wei J; Chen DW
    Biomed Chromatogr; 2006 Nov; 20(11):1223-8. PubMed ID: 16799932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injectable chitosan thermogels for sustained and localized delivery of pingyangmycin in vascular malformations.
    Chen F; Song S; Wang H; Zhang W; Lin C; Ma S; Ye T; Zhang L; Yang X; Qin X; Pan W
    Int J Pharm; 2014 Dec; 476(1-2):232-40. PubMed ID: 25283699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin-loaded Zein in situ gel for interstitial chemotherapy.
    Cao X; Geng J; Su S; Zhang L; Xu Q; Zhang L; Xie Y; Wu S; Sun Y; Gao Z
    Chem Pharm Bull (Tokyo); 2012; 60(10):1227-33. PubMed ID: 22863745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of the Antitumor Efficacy of Intratumoral Administration of Cucurbitacin Poly(Lactic-co-Glycolic Acid) Microspheres Incorporated in In Situ-Forming Sucrose Acetate Isobutyrate Depots.
    Wang JW; Xu JH; Li J; Zhao MH; Zhang HF; Liu DC; Zhou X; Xu H
    J Pharm Sci; 2016 Jan; 105(1):205-11. PubMed ID: 26566075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thermosensitive in situ gel of boanmycin hydrochloride for injection].
    Ding WM; Li M; Li GL; Xu HZ; Chen RX
    Yao Xue Xue Bao; 2011 Jun; 46(6):727-32. PubMed ID: 21882536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleomycin A6-loaded anionic liposomes with in situ gel as a new antitumoral drug delivery system.
    Ding W; Li Y; Hou X; Li G
    Drug Deliv; 2016; 23(1):88-94. PubMed ID: 24845479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sucrose acetate isobutyrate as an in situ forming system for sustained risperidone release.
    Lu Y; Yu Y; Tang X
    J Pharm Sci; 2007 Dec; 96(12):3252-62. PubMed ID: 17721936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of Pingyangmycin-loaded bovine serum albumin microspheres for embolization therapy.
    Wang C; Liu J; Gao Q; Bi Y; Gan L; Wang X; Hou S
    Int J Pharm; 2007 May; 336(2):361-6. PubMed ID: 17360133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracranial drug-delivery scaffolds: biocompatibility evaluation of sucrose acetate isobutyrate gels.
    Lee J; Jallo GI; Penno MB; Gabrielson KL; Young GD; Johnson RM; Gillis EM; Rampersaud C; Carson BS; Guarnieri M
    Toxicol Appl Pharmacol; 2006 Aug; 215(1):64-70. PubMed ID: 16630637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Embolization and degradation of arteries in vivo by pingyangmycin albumin microspheres].
    Wang LL; Gao QH; Zheng GJ; Wang XY; Zhou L; Wang CM; Wen YM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):279-83. PubMed ID: 19462907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sucrose Acetate Isobutyrate as an In situ Forming Implant for Sustained Release of Local Anesthetics.
    Li H; Xu Y; Tong Y; Dan Y; Zhou T; He J; Liu S; Zhu Y
    Curr Drug Deliv; 2019; 16(4):331-340. PubMed ID: 30451111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan-based liposomal thermogels for the controlled delivery of pingyangmycin: design, optimization and in vitro and in vivo studies.
    Zhang L; Chen F; Zheng J; Wang H; Qin X; Pan W
    Drug Deliv; 2018 Nov; 25(1):690-702. PubMed ID: 29484910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparation of lymphatic targeting dosage form: pingyangmycin absorbed on activated carbon nanoparticles].
    Sun ML; Wen YM; Wang CM; Li LJ; Wang XY
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Jun; 22(3):183-5. PubMed ID: 15293458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous Treatment of Large Venous Malformations in the Oral and Maxillofacial Regions Using Electrochemical Therapy Combined With Pingyangmycin.
    Xue L; Cao RY; Xu DP; Sun NN; Tan HS; Wang XK
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1384-91. PubMed ID: 25913514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of a CD13/APN-targeting and hydrolase-resistant conjugate that comprises pingyangmycin and NGR motif-integrated apoprotein.
    Li B; Zheng YB; Li DD; Zhen YS
    J Pharm Sci; 2014 Apr; 103(4):1204-13. PubMed ID: 24504597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pingyangmycin loaded bovine serum albumin microspheres for chemoembolization therapy--in vitro and in vivo studies.
    Wang C; Liu J; Pan W; Wang X; Gao Q; Hou S
    Int J Pharm; 2008 Mar; 351(1-2):219-26. PubMed ID: 18054185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vivo distribution of FITC-labeled boanmycin hydrochloride in situ gel].
    Wang ZH; Ding WM; Qian LX; Li M; Xu HZ; Chen RX
    Yao Xue Xue Bao; 2012 May; 47(5):634-9. PubMed ID: 22812009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rheological properties of sucrose acetate isobutyrate in situ gel].
    Lu YX; He HB; Cui Y; Tang X
    Yao Xue Xue Bao; 2007 Apr; 42(4):445-9. PubMed ID: 17633217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pingyangmycin gelatin microspheres: preparation and drug release characteristics].
    Wu H; Wu D; Yu K; Feng X; Yao Z
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Dec; 20(4):646-9. PubMed ID: 14716867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.